ID: ALA2303823

Max Phase: Preclinical

Molecular Formula: C24H32N6O10

Molecular Weight: 370.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(NCc2cnc3nc(N)nc(N)c3c2C)cc(OC)c1OC.O=C(O)[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C18H22N6O3.C6H10O7/c1-9-10(8-22-17-14(9)16(19)23-18(20)24-17)7-21-11-5-12(25-2)15(27-4)13(6-11)26-3;7-1-2(8)4(5(10)11)13-6(12)3(1)9/h5-6,8,21H,7H2,1-4H3,(H4,19,20,22,23,24);1-4,6-9,12H,(H,10,11)/t;1-,2-,3+,4-,6-/m.0/s1

Standard InChI Key:  GYBNBSCSQPITAU-LQGIGNHCSA-N

Associated Targets(non-human)

Pneumocystis carinii 749 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 370.41Molecular Weight (Monoisotopic): 370.1753AlogP: 2.14#Rotatable Bonds: 6
Polar Surface Area: 130.43Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.10CX LogP: 1.39CX LogD: 1.39
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.60Np Likeness Score: -0.49

References

1. Gangjee A, Shi J, Queener SF, Barrows LR, Kisliuk RL..  (1993)  Synthesis of 5-methyl-5-deaza nonclassical antifolates as inhibitors of dihydrofolate reductases and as potential antipneumocystis, antitoxoplasma, and antitumor agents.,  36  (22): [PMID:8230134] [10.1021/jm00074a026]

Source